BEAM Q2 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-28.1% YoY

Gross Profit

-$93M-1102.0% margin

Operating Income

-$120M-1419.2% margin

Net Income

-$102M-1208.3% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

+13.3%

Cash Flow

Operating Cash Flow

-$76M

Free Cash Flow

-$80M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$344M

Stockholders' Equity

$1.0B

Cash & Equivalents

$282M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$12M	-28.1%
Gross Profit	-$93M	$12M	-892.5%
Operating Income	-$120M	-$105M	-14.5%
Net Income	-$102M	-$91M	-12.3%